OIL & GAS

RMC Biosciences, Inc. and The Business Intelligence Network announced today the launch of a new online Bioinformatics Channel. The new channel provides timely information about the Bioinformatics industry and its role in biopharmaceutical markets, life sciences research, and the discovery of new drug compounds. The Bioinformatics Channel includes monthly articles on current topics in bioinformatics, industry events, news releases, insightful opinion pieces, industry and trade association links, white papers and reports, and other topics of interest to the industry community. Bioinformatics is a broad field including Information Technology, computational biology, software applications and databases, and the computational resources used to model biological systems in both normal and diseased states. The Channel aggregates these many topics in a single location and provides insightful analysis of current industry trends. Dr. Richard Casey, the Founder and Chief Scientific Officer of RMC Biosciences, stated, " Bioinformatics is the foundation for Computer Aided Drug Design, drug discovery, and the development of new drug compounds. It’s a rapidly growing field that has a direct impact on genomics, proteomics, biopharmaceutical markets, and research in the life sciences. The Bioinformatics Channel brings together timely, informative, and entertaining news in one online location, and should be of interest to anyone using bioinformatics applications and databases in life sciences research." "I am very pleased to announce the launch of the Channel on the Business Intelligence Network with Dr. Richard Casey who is an expert in Bioinformatics and Computer Aided Drug Design," said Ron Powell, the Editorial Director for the B-EYE-Network. "The Bioinformatics Channel is dedicated to coverage of the business issues facing today's Bioinformatics industry and the usage of business intelligence, business performance management, data warehousing and information technology in addressing those challenges."